Transaction Date | Recipient | Shares | Type | Price | Value |
---|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008.